U.S., March 13 -- ClinicalTrials.gov registry received information related to the study (NCT07468123) titled 'Atrial Fibrillation Risk Estimation With Single-lead Handheld Electrocardiograms' on March 09.
Brief Summary: The goal of this prospective, non-randomized pilot study is to learn whether predictions from a previously validated 12-lead ECG-based artificial intelligence (AI) algorithm (ECG-AI) identify people more likely to have undiagnosed atrial fibrillation (AF).
The main questions it aims to answer are:
Do people predicted to have high risk of AF using ECG-AI have a higher rate of new AF diagnosis using 1L ECG screening compared with people predicted to have a low risk? Do AI-based AF risk estimates from the 12-lead ECG correla...